Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
RMTI Rockwell Medical Inc
- Stocks
- Healthcare
- NASDAQ: RMTI
Price (delayed)
$1.01
Market cap
$34.52M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.02
Enterprise value
$35.99M
Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients. The
Highlights
The net income has soared by 97% YoY and by 45% QoQ
The EPS has soared by 94% YoY and by 33% from the previous quarter
RMTI's equity has surged by 53% year-on-year but it is down by 3.3% since the previous quarter
Rockwell Medical's revenue has increased by 13% YoY but it has decreased by 3.7% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.rockwellmed.com
Key stats
What are the main financial stats of RMTI
Market
Valuations
Earnings
Shares outstanding
34.17M
Market cap
$34.52M
Enterprise value
$35.99M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.09
Price to sales (P/S)
0.35
EV/EBIT
43.05
EV/EBITDA
7.24
EV/Sales
0.37
Revenue
$97.73M
Gross profit
$17.46M
Operating income
$572,000
Net income
-$264,000
EBIT
$836,000
EBITDA
$4.97M
Free cash flow
$2.16M
Per share
Balance sheet
Liquidity
EPS
-$0.02
EPS diluted
-$0.03
Free cash flow per share
$0.06
Book value per share
$0.93
Revenue per share
$2.87
TBVPS
$1.26
Total assets
$53.96M
Total liabilities
$22.44M
Debt
$12.87M
Equity
$31.52M
Working capital
$21.83M
Debt to equity
0.41
Current ratio
2.95
Quick ratio
2.41
Net debt/EBITDA
0.3
Margins
Efficiency
Dividend
EBITDA margin
5.1%
Gross margin
17.9%
Net margin
-0.3%
Operating margin
0.6%
Return on assets
-0.5%
Return on equity
-0.9%
Return on invested capital
2.6%
Return on capital employed
2%
Return on sales
0.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RMTI stock price
How has the Rockwell Medical stock price performed over time
Intraday
3.09%
1 week
-9.82%
1 month
-1.94%
1 year
-41.95%
YTD
-50.49%
QTD
-10.62%
Financial performance
How have Rockwell Medical's revenue and profit performed over time
Revenue
$97.73M
Gross profit
$17.46M
Operating income
$572,000
Net income
-$264,000
Gross margin
17.9%
Net margin
-0.3%
Rockwell Medical's operating income has surged by 109% YoY but it has decreased by 6% QoQ
The company's operating margin has surged by 108% YoY
The company's net margin has surged by 97% YoY and by 40% QoQ
The net income has soared by 97% YoY and by 45% QoQ
Price vs fundamentals
How does RMTI's price correlate with its fundamentals
Growth
What is Rockwell Medical's growth rate over time
Valuation
What is Rockwell Medical stock price valuation
P/E
N/A
P/B
1.09
P/S
0.35
EV/EBIT
43.05
EV/EBITDA
7.24
EV/Sales
0.37
The EPS has soared by 94% YoY and by 33% from the previous quarter
RMTI's price to book (P/B) is 71% lower than its 5-year quarterly average of 3.8 and 55% lower than its last 4 quarters average of 2.4
RMTI's equity has surged by 53% year-on-year but it is down by 3.3% since the previous quarter
RMTI's price to sales (P/S) is 61% lower than its 5-year quarterly average of 0.9 and 50% lower than its last 4 quarters average of 0.7
Rockwell Medical's revenue has increased by 13% YoY but it has decreased by 3.7% from the previous quarter
Efficiency
How efficient is Rockwell Medical business performance
The ROS has soared by 113% YoY and by 13% from the previous quarter
The return on invested capital has surged by 112% year-on-year and by 4% since the previous quarter
RMTI's return on equity has surged by 98% year-on-year and by 50% since the previous quarter
Rockwell Medical's return on assets has surged by 97% YoY and by 44% QoQ
Dividends
What is RMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RMTI.
Financial health
How did Rockwell Medical financials performed over time
Rockwell Medical's total assets is 140% more than its total liabilities
RMTI's quick ratio has soared by 83% YoY and by 14% QoQ
RMTI's current ratio has soared by 65% YoY and by 12% QoQ
The company's debt is 59% lower than its equity
RMTI's equity has surged by 53% year-on-year but it is down by 3.3% since the previous quarter
The debt to equity has contracted by 41% YoY and by 2.4% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.